Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Investing in your 20s can set the foundation for a secure retirement. Discover the best options to maximize your growth.
17,680 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Red Cat stock faced a sharp move that sparked questions about its future. This article breaks down what can cause a s...
Uber stock has slipped about 12% in three months, trading near $74 after a strong run. This article breaks down what’...
Oracle slipped this year, but does that mean it's a no-brainer AI buy? This practical guide weighs AI potential, fina...
STAG and EastGroup Properties stand out in the warehouse REIT space. This guide compares portfolio strategy, growth d...
A 70,000-seat return in a government-backed venue stirs more than cheers. This article breaks down the money side of ...
As Berkshire Hathaway prepares for a new era, Warren Buffett successor Greg Abel may be quietly orchestrating a bold,...
A clear, actionable preview of ABM's Q2 2026 results. Learn what the (abm) 2026 earnings call could reveal about reve...
A Brooklyn convenience store operator is charged with using stolen Ohio EBT card numbers to pull off nearly 3,000 fra...
Twilio stocks have seen a pullback after a strong run. This guide explains how to assess whether you should twilio di...
An elderly investor nearly drained her savings after a deceptive pop-up steered her toward buying gold. This article ...
Imagine a space tech powerhouse going public and shaping Wall Street expectations. This article lays out three plausi...